GSK Investigational Site

Bad Lauterberg im Harz, Lower Saxony 37431

0 studies enrolling now · 5 studies all time

What they study most

Diabetes Mellitus, Type 1, Diabetes Mellitus, Type 2

Studies at this site

• A New Oral Treatment For Type II Diabetes Mellitus — Completed
• Trial of Otelixizumab for Adults With Newly Diagnosed Type 1 Diabetes Mellitus (Autoimmune): DEFEND-1 — Completed
• A Study of the Efficacy and Safety of Albiglutide in Subjects With Type 2 Diabetes With Renal Impairment. — Completed
• Efficacy and Safety of Albiglutide in Treatment of Type 2 Diabetes — Completed
• A Study to Determine the Safety and Efficacy of Albiglutide in Subjects With Type 2 Diabetes — Completed